<DOC>
	<DOC>NCT00696722</DOC>
	<brief_summary>The purpose of this study is to determine whether atazanavir use is of influence on the endothelial dysfunction associated with type 2 diabetes mellitus.</brief_summary>
	<brief_title>Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>Inclusion Criteria (most important): 18 70 years type 2 diabetes mellitus treated with diet, oral medication and/or insulin BMI of 18 to 35 determinants of renal and hepatic function within twice the upper limit of normal range, abnormalities in lipid profile permitted Exclusion Criteria (most important): history of smoking within past year history of or current abuse of drugs, alcohol or solvents current use of antihypertensive, cardiac or other vasoactive medication clinical evidence of cardiac or pulmonary disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>